KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹7.04 Cr | ₹-14 Cr | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹7.04 Cr |
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-17 Cr |
| Mar2023 | ₹0.99 Cr |
| Mar2022 | ₹5.66 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.04 Cr | Positive | |
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-17 Cr | Negative | |
| Mar2023 | ₹0.99 Cr | -82.43 | |
| Mar2022 | ₹5.66 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,837.2 Cr | 6.2% | -1.6% | 317.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 6.2% |
-1.6% |
317.8% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses